دورية أكاديمية

P78.01 Nivolumab in Second Line Non-Small Cell Lung Cancer – Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057

التفاصيل البيبلوغرافية
العنوان: P78.01 Nivolumab in Second Line Non-Small Cell Lung Cancer – Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057
المؤلفون: Popat, S., Tanna, N., Hartridge-Lambert, S., Kiff, C., Sowdani, A., Rothwell, B., Henrik-Brodtkorb, T., Ling, C., Smittenaar, R., Bomb, M., Turnbull, A., Lawton, S.
المصدر: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S637-S638
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2021.01.1164